TOP STORY: Dei BioPharma chief Dr. Magoola publishes groundbreaking research on RNA-Based Cancer Therapy
Dr. Magoola has over 100 patents in advanced therapies filed in the US KAMPALA - Dr. Matthias Magoola, the founder and Managing Director ...
Dr. Magoola has over 100 patents in advanced therapies filed in the US KAMPALA - Dr. Matthias Magoola, the founder and Managing Director ...
Dr. Matthias Magoola, founder and CEO of Dei Group of Companie KYOTERA — President Yoweri Museveni has praised Dei BioPharma ...
© 2024 Ugstandard - Latest News by Digital/New Media company.